These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2050587)

  • 21. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W; Dick W; Stieglitz M; Opferkuch W
    Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug-resistance analysis of Gram-negative bacilli producing extended-spectrum beta-lactamases in lower respiratory tract infection].
    Long J; Lü SC
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):439-40, 444. PubMed ID: 15090319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
    Lanzafame A; Bonfiglio G; Santini L; Mattina R
    Chemotherapy; 2005 Mar; 51(1):44-50. PubMed ID: 15767745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.
    Just HM; Becker C; Gieringer J; Wenz A; Bassler M; Daschner F
    Drugs; 1985; 29 Suppl 5():74-7. PubMed ID: 4029031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of temocillin against clinical isolates.
    Van Landuyt HW; Boelaert J; Piot P; Verbist L
    Drugs; 1985; 29 Suppl 5():1-8. PubMed ID: 4029009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of extended spectrum beta lactamase mediated resistance in neonatal septicemia.
    Vinodkumar CS; Neelagund YF
    Indian J Pathol Microbiol; 2006 Oct; 49(4):616-9. PubMed ID: 17183878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units.
    Glupczynski Y; Huang TD; Berhin C; Claeys G; Delmée M; Ide L; Ieven G; Pierard D; Rodriguez-Villalobos H; Struelens M; Vaneldere J
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):777-83. PubMed ID: 17668253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
    Alexandre K; Chau F; Guérin F; Massias L; Lefort A; Cattoir V; Fantin B
    J Antimicrob Chemother; 2016 Jul; 71(7):1899-904. PubMed ID: 27029848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
    Soubirou JF; Rossi B; Couffignal C; Ruppé E; Chau F; Massias L; Lepeule R; Mentre F; Fantin B
    J Antimicrob Chemother; 2015 May; 70(5):1466-72. PubMed ID: 25564564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temocillin (BRL 17421): in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1982 Oct; 10(4):271-8. PubMed ID: 6982892
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
    Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Uehara N; Yasujima M; Kasai T; Suwabe A; Yamahata K; Kaku M; Kanemitsu K; Imafuku Y; Nishiyama K; Murakami M; Yomoda S; Taniguchi N; Yamada T; Nomura F; Watanabe M; Kanno H; Aihara M; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Yamazaki F; Horii T; Maekawa M; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Iinuma Y; Maeda S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kinoshita S; Fujita J; Negayama K; Murase M; Miyamoto H; Kusano N; Mihara E; Itaha H; Ono J; Yoshimura H; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
    Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
    Zhao WH; Asano N; Hu ZQ; Shimamura T
    J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.
    Li H; Estabrook M; Jacoby GA; Nichols WW; Testa RT; Bush K
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1789-93. PubMed ID: 25534728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011.
    Hawser SP; Badal RE; Bouchillon SK; Hoban DJ; Hackel MA; Biedenbach DJ; Goff DA
    J Infect; 2014 Jan; 68(1):71-6. PubMed ID: 24016768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in-vitro activity and beta-lactamase stability of carumonam.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic].
    Inoue E; Komoto E; Taniyama Y; Mitsuhashi S
    Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro antibacterial properties of 2-(3-bromo-5-isoxazolylideneamino-oxy)acetamido-beta-lactam derivatives.
    Sala A; Chiarino D; Napoletano M; Albini E; Carenzi A
    Farmaco; 1991; 46(7-8):887-97. PubMed ID: 1793473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.